Seegene Boosts ESG Rating by Korea Institute of Corporate Governance and Sustainability

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on November 10 that it has rece...

November 24, 2023 | Friday | News
Fapon Accelerates the Development of its Diagnostic Ecosystem

With a steadfast dedication of 22 years to advancing the fundamental technologies of raw materials, reagent and instrument, Fapon strives to empower the gl...

November 24, 2023 | Friday | News
CMI Inc. and Life Molecular Imaging Secure Reimbursement for Amyloid-PET Diagnostic Neuraceq® in Japan

CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic  Neuraceq® (florbetaben 18F injection) has ...

November 23, 2023 | Thursday | News
GE Healthcare Launches Enhanced Digital Expert Access for Remote Patient Scans, Secures Exclusive Distribution Deal with IONIC Health

GE HealthCare (Nasdaq: GEHC) has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access with remote scanning, the first remote pat...

November 22, 2023 | Wednesday | News
AstraZeneca's Global Initiative Surpasses 1 Million Lives Touched in the Fight Against Lung Cancer

Major Milestone Met in AI-Powered Fight Against Lung Cancer Global initiative gains significant ground in digitally identifying cancer risk before s...

November 22, 2023 | Wednesday | News
Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

“We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exacte...

November 21, 2023 | Tuesday | News
Owl Therapeutics and Abliva Collaborate on NeuroSTAT® for Traumatic Brain Injury

TBI is an urgent and prominent public health challenge, impacting millions each year as a result of head trauma from accidents, falls, sports-related incid...

November 20, 2023 | Monday | News
Medtronic announces FDA approval of minimally invasive device to treat hypertension

Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology Medtronic plc (NYSE: MDT), a ...

November 20, 2023 | Monday | News
NYU Langone Health Partners with Philips for Patient Safety and Quality Outcomes

 Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, and NYU Langone Health, the nation’s top-ranked academic medical cen...

November 17, 2023 | Friday | News
SciSparc Celebrates Major Breakthrough with Positive Results Demonstrating Remarkable Impact on Alzheimer's Agitation in Treatment

SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central...

November 16, 2023 | Thursday | News
QIAGEN Introduces TissueLyser III and RNeasy PowerMax Soil Pro Kit for Enhanced Sample Processing and RNA Isolation

QIAGEN announced the expansion of its sample technologies portfolio with the introduction of two new products aimed at supporting researchers in managing d...

November 16, 2023 | Thursday | News
Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio

These loose cortical fibers are engineered to complement specific surgical applications in the foot and ankle and are flexible upon hydration allowing for ...

November 15, 2023 | Wednesday | News
Charles River and Aitia Partner to Advance Logica in Neurodegenerative and Oncology Discoveries

Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make an eq...

November 14, 2023 | Tuesday | News
Hepion Pharmaceuticals Reports Significant Liver Stiffness Reduction in Advanced MASH Liver Disease Study

Demonstrated improvements among best reported of fibrosis-reducing compounds - - Liver stiffness results complemented by positive changes in disease bioma...

November 14, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close